Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Elizabeth R Kessler"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/b5dc8bfbe1a14acd9235449212e303f7
Publikováno v:
Aging and Cancer, Vol 3, Iss 2, Pp 105-115 (2022)
Abstract Background Bladder cancer is one of the top 10 cancers diagnosed in Americans with a median age of 73. This is the patient population that tends to be older with multiple medical conditions, and previously described variability in treatment
Externí odkaz:
https://doaj.org/article/a68e19d236f844029143462d1cdb1b04
Autor:
Vinay Kini, Bridget Mosley, Julie Ressalam, Dragana Bolcic-Jankovic, Hillary D. Lum, Elizabeth R. Kessler, Matthew DeCamp, Eric G. Campbell
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Physicians who participate in medical-aid-in-dying (MAID) cannot be easily identified and studied due to cost and anonymity barriers. We developed and empirically tested a novel methodology to identify and survey physicians highly likely to
Externí odkaz:
https://doaj.org/article/771ccd54956846f3b1c44bdfdb0f8a61
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
The incidence of severe immune-related adverse events (irAEs) in cancer subjects receiving immune checkpoint inhibitors (ICIs) following COVID-19 vaccination and the relationship between the incidence of severe irAE and the interval between COVID-19
Externí odkaz:
https://doaj.org/article/162bdedf4f734f7e91ca7dcf11febc3d
Autor:
Crystal S. Langlais MPH, Yea-Hung Chen PhD, Erin L. Van Blarigan ScD, Stacey A. Kenfield ScD, Elizabeth R. Kessler MD, Kimi Daniel MS, Justin W. Ramsdill MS, Tomasz M. Beer MD, Rebecca E. Graff ScD, Kellie Paich MPH, June M. Chan ScD, Kerri M. Winters-Stone PhD
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
Background: Following a prostate cancer (PC) diagnosis, treatment-related symptoms may result in diminished quality of life (QoL). Improved diet and increased exercise may improve QoL in men with PC. Methods: We conducted a 4-arm pilot randomized tri
Externí odkaz:
https://doaj.org/article/5ce37a7b52f84f20a42792e4b5a539a0
Autor:
Alaina L. Carr, Emily Bilenduke, Esmeralda Adolf, Elizabeth R. Kessler, Joanna J. Arch, Krista W. Ranby, Kristin Kilbourn
Publikováno v:
Palliative and Supportive Care. :1-9
Objectives Caregivers of adult phase 1 oncology trial patients experience high levels of distress and face barriers to in-person supportive care. The Phase 1 Caregiver LifeLine (P1CaLL) pilot study assessed the feasibility, acceptability, and general
Autor:
Elizabeth R. Kessler MD, Lih-Jen Su, Dexiang Gao, Kathleen C. Torkko, Michael Wacker, Mary Anduha, Nicole Chronister, Paul Maroni MD, E. David Crawford MD, Thomas W. Flaig MD, L. Michael Glode MD, Elaine T. Lam MD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Background: Plant derivatives have been studied as therapies for prostate cancer based on their purported anti-inflammatory and antioxidant properties and low toxicities. The acai berry is an example of a plant rich in phytochemicals, which may slow
Externí odkaz:
https://doaj.org/article/d5910d764b1d4373bf177bea762c4f17
Autor:
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
Publikováno v:
Cancer Research Communications.
Purpose: Immune checkpoint inhibitor and vascular endothelial growth factor receptor inhibitor combinations are effective treatments for patients with metastatic renal cell carcinoma (mRCC). This phase 1/2 clinical trial evaluated the safety and effi
Autor:
Elizabeth R Kessler, Julie Ressalam, Matthew DeCamp, Hillary D Lum, Vinay Kini, Eric G Campbell
Publikováno v:
The Oncologist.
In Colorado, medical aid in dying (MAiD) is legal, allowing a terminally ill person to request a prescription and self-administer a medication to end their life. Such requests are granted under certain circumstances, including a malignant neoplasm di
Autor:
Laura S. Graham, John K. Lin, Daniel E. Lage, Elizabeth R. Kessler, Ravi B. Parikh, Alicia K. Morgans
Publikováno v:
American Society of Clinical Oncology Educational Book.
The majority of men with prostate cancer are diagnosed when they are older than 65 years; however, clinical trial participants are disproportionately younger and more fit than the real-world population treated in typical clinical practices. It is, th